| scholarly article | Q13442814 |
| P50 | author | Jos Bloemers | Q57025496 |
| Henderik W Frijlink | Q63364127 | ||
| P2093 | author name string | Adriaan Tuiten | |
| Berend Olivier | |||
| Kim van Rooij | |||
| Leo de Leede | |||
| Hans P F Koppeschaar | |||
| P2860 | cites work | DSM-5 | Q3064664 |
| Central inhibition of sexual response in the male: a theoretical perspective | Q33762764 | ||
| Pharmacokinetics of a prototype formulation of sublingual testosterone and a buspirone tablet, versus an advanced combination tablet of testosterone and buspirone in healthy premenopausal women | Q33804785 | ||
| Sexual dysfunction in the United States: prevalence and predictors | Q33852255 | ||
| Time course of effects of testosterone administration on sexual arousal in women | Q33889244 | ||
| Testosterone decreases trust in socially naive humans | Q33933304 | ||
| Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality | Q34117094 | ||
| Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women | Q34514661 | ||
| Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group | Q34747116 | ||
| Prejudice and truth about the effect of testosterone on human bargaining behaviour | Q35016801 | ||
| Pharmaceutical applications of cyclodextrins: basic science and product development | Q37805590 | ||
| A single administration of testosterone induces cardiac accelerative responses to angry faces in healthy young women | Q43546320 | ||
| Testosterone administration in women increases amygdala responses to fearful and happy faces | Q43555583 | ||
| The age-associated decline of androgens in reproductive age and menopausal Black and White women | Q43719070 | ||
| The enhancement of vaginal vasocongestion by sildenafil in healthy premenopausal women | Q44084236 | ||
| Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without vardenafil on physiological sexual arousal in women with sexual dysfunction: a pilot study | Q44165590 | ||
| Effect of four different oral contraceptives on various sex hormones and serum-binding globulins | Q44274326 | ||
| Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods | Q44757073 | ||
| A single administration of testosterone improves visuospatial ability in young women | Q44812218 | ||
| Decoupling of midfrontal delta-beta oscillations after testosterone administration | Q44917350 | ||
| Testosterone shifts the balance between sensitivity for punishment and reward in healthy young women | Q44921327 | ||
| Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms. | Q45966469 | ||
| The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction. | Q46126587 | ||
| Testosterone reduces unconscious fear but not consciously experienced anxiety: implications for the disorders of fear and anxiety | Q46530958 | ||
| Menstrual cycle-related changes in circulating androgens in healthy women with self-reported normal sexual function | Q46678966 | ||
| Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues | Q46704357 | ||
| Exogenous testosterone attenuates the integrated central stress response in healthy young women | Q46975493 | ||
| Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder. | Q48306257 | ||
| The clitoral photoplethysmograph: a new way of assessing genital arousal in women. | Q48598293 | ||
| Reduced gray matter volume and increased white matter fractional anisotropy in women with hypoactive sexual desire disorder | Q48828839 | ||
| Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women | Q48855607 | ||
| The relationship between self-reported sexual satisfaction and general well-being in women. | Q50725920 | ||
| Exogenous testosterone enhances responsiveness to social threat in the neural circuitry of social aggression in humans. | Q50889932 | ||
| Testosterone reduces conscious detection of signals serving social correction: implications for antisocial behavior. | Q50892582 | ||
| Sexual problems and distress in United States women: prevalence and correlates. | Q51675955 | ||
| Testosterone administration reduces empathetic behavior: a facial mimicry study. | Q51800350 | ||
| Effects of testosterone administration on selective aspects of object-location memory in healthy young women. | Q51976934 | ||
| Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes | Q84728460 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 1091-1102 | |
| P577 | publication date | 2016-01-25 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Single dose sublingual testosterone and oral sildenafil vs. a dual route/dual release fixed dose combination tablet: a pharmacokinetic comparison | |
| P478 | volume | 81 |
| Q90285194 | Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial |
| Q50088331 | How publication guidelines for clinical pharmacology trials may help to accelerate knowledge transfer. |
| Q89843781 | The Effect of Food on the Pharmacokinetics of Buspirone After Single Administration of a Sublingual Testosterone and Oral Buspirone Combination Tablet in Healthy Female Subjects |
Search more.